Global /China /Healthcare /Medical Devices /300439

Medicalsystem Biotechnology Co., Ltd.

300439

• SHE: 300439 • Delayed

10.09CNY 0%

1.49 USD

As of 14 June 2026, Medicalsystem Biotechnology Co., Ltd. has a market cap of $572.28M USD, ranking #14233 globally and #4390 in China. It ranks #1268 in the Healthcare sector, and #253 in the Medical Devices industry.

Global Rank

14233

Country Rank

4390

Sector Rank

1268

Industry Rank

253

Key Stats

Market Cap

$572.28MUSD

3.88B CNY

Enterprise Value

$444.4MUSD

3.01B CNY

Revenue (TTM)

$227.15MUSD

1.54B CNY

EBITDA (TTM)

$32.4MUSD

219.28M CNY

Net Income (TTM)

$9.33MUSD

63.2M CNY

EBITDA Margin

14%

Profit Margin

4.1%

PE Ratio

63.1

PS Ratio

2.5

PB Ratio

1.3

EV/EBITDA

13.2

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Medical Devices

CEO

Ji Hua Zou open_in_new

Employees

2,104

Founded

2003

Website

nbmksw.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	4.7%	4%	-1.8%	-1.7%	2.4%	0.5%	-16%	-53%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	300439 美康生物科技股份有限公司 Class A ISIN: CNE100001Z25 Shares Out.: Shares Outstanding: 383.844M¹ Shares Float: 344.918M² TV: TradingView: SZSE: 300439 SA: Stock Analysis: SHE: 300439 YF: Yahoo Finance: 300439.SZ GF: Google Finance: SHE: 300439 BA: Barron's: 300439 MS: Morningstar: XSHE: 300439	10.09 CNY	TV: TradingView: SZSE: 300439 SA: Stock Analysis: SHE: 300439 YF: Yahoo Finance: 300439.SZ GF: Google Finance: SHE: 300439 BA: Barron's: 300439 MS: Morningstar: XSHE: 300439

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Medicalsystem Biotechnology Co., Ltd.

Medicalsystem Biotechnology Co., Ltd. engages in the research, development, production, and sales of in vitro diagnostic products in China. It is also involved in the provision of Three-party medical diagnosis services. The company offers automated chemistry analyzers; and automated chemiluminescence immunoassay analyzer; hematology analyzers and reagents; total laboratory automation system; mass spectrometry; and, blood lipid subfraction analyzer, and POCT.It also provides healthcare services. Medicalsystem Biotechnology Co., Ltd. was formerly known as Ningbo Medicalsystem Biotechnology Co., Ltd. and changed its name to Biotechnology Co., Ltd. in January 2017. Medicalsystem Biotechnology Co., Ltd. was founded in 2003 and is based in Ningbo, China.

Similar Companies

Industry: Medical Devices (China)

Name	Market Cap (USD) diff.	PE	Country
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. SHE: 300760	$30.06B 203.66B CNY 5K%	26.0	China
Shanghai United Imaging Healthcare Co., Ltd. SSE: 688271	$13.61B 92.23B CNY 2K%	48.5	China
Shenzhen New Industries Biomedical Engineering Co., Ltd. SHE: 300832	$5.61B 38.02B CNY 880%	23.4	China
Intco Medical Technology Co., Ltd. SHE: 300677	$5.52B 37.43B CNY 865%	52.7	China
APT Medical Inc. SSE: 688617	$5.04B 34.14B CNY 780%	39.6	China
Andon Health Co., Ltd. SHE: 002432	$4.55B 30.86B CNY 696%	13.7	China

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 30K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 28K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 28K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 22K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 21K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 18K%	22.2	Ireland

chevron_leftBack